¼º¼®ÁÖ
¼Ò
¼Ó
: °³²Â÷º´¿ø
Àü¹®ºÐ¾ß : ºÎÀξÏ, ÀڱñÙÁ¾, ³¼ÒÁ¾¾ç,·Îº¿¼ö¼ú, º¹°°æ,Àڱðæ, ´ÜÀÏ°ø¼ö¼ú
Á÷
ˤ
: ±³¼ö
¸Þ
ÀÏ
:
.
Àü
È
:
02.3468.3000
ÆÑ
½º
:
02.558.1119
ÁÖ
¼Ò
:
¼¿ï½Ã °³²±¸ ¿ª»ï1µ¿ 650-9
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
114
ÇØ¿Ü
Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline.
113
ÇØ¿Ü
Evidence for No Significant Impact of Müllerian Anomalies on Reproductive Outcomes of Twin Pregnancy in Korean Women.
112
ÇØ¿Ü
Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial.
111
ÇØ¿Ü
Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial.
110
ÇØ¿Ü
Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
109
ÇØ¿Ü
Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group.
108
ÇØ¿Ü
Controversies in borderline ovarian tumors.
107
ÇØ¿Ü
Microscopic Omental Metastasis in Clinical Stage I Endometrial Cancer: A Meta-analysis.
106
±¹³»
Successful delivery after conservative resectoscopic surgery in a patient with a uterine tumor resembling ovarian sex cord tumor with myometrial invasion.
105
ÇØ¿Ü
Management of Endometrial Hyperplasia: A Survey of Members of the Korean Gynecologic Oncology Group.
1
2
3
4
5
6
7
8
9
10
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729